Safety and Tolerability of Intravenous Administration of ICVB-1042

NCT05904236 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

17

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of Demonstrated Clinical Activity

Conditions

Patients With Advanced Solid Tumors

Interventions

DRUG: Treatment with ICVB-1042 administered intravenously

Sponsor

IconOVir Bio